1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Prof. Janet Dunn: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol - Myelodysplastic Syndromes (MDS) | Phase 2 | Unknown | Prof. Janet Dunn | 120 | 2021-12-21 | 2023-10-03 |
Bezafibrate (1) · Danazol (1) · Medroxyprogesterone (1) · Valproic Acid (1)
United Kingdom (1)